Differential response of normal and transformed mammary epithelial cells to combined treatment of anti-miR-21 and radiation
Open Access
- 9 January 2017
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 93 (4) , 361-372
Abstract
Purpose: MicroRNA miR-21 has emerged as a therapeutic target in the treatment of breast cancer. This study was designed to compare the responses of breast cancer cells and non-transformed breast epithelial cells to a combined regimen of miR-21 inhibition and radiation. Materials and methods: The MDA-MB-361 (breast cancer) and MCF-10A (non-transformed mammary epithelial) cell lines were used for the comparison in this in vitro study. The stable knockdown of miR-21 was performed by using lentiviral approach. The response of the cells was monitored 4, 24 and 48 h after the irradiation with 0.25 and 2.5 Gy, using sham-irradiated cells as controls. The response of the cells was established by performing various functional assays – cell viability and cell attachment, clonogenic survival, cell cycle analysis and 3D microtissue formation. Results: The knockdown of miR-21 induced significant increase in apoptosis and growth delay in MDA-MB-361 cancer cells compared to non-transformed MCF-10A cells. After combined radiation and anti-miR-21 treatment, MDA-MB-361 cells show reduced cell growth and viability what is presented in their inability to form colonies. MCF-10A cells were not as sensitive to the combined treatment and that has also been confirmed with colony forming assay. Conclusions: Cellular response to a combined treatment of anti-miR-21 and radiation is different between cancer and non-cancer cells which highly support the idea of linking miR-21 inhibitor and radiation treatment in the future therapeutic approaches for breast cancer.Keywords
This publication has 43 references indexed in Scilit:
- A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatmentBMC Cancer, 2015
- Role of MicroRNA in Response to Ionizing Radiations: Evidences and Potential Impact on Clinical Practice for RadiotherapyMolecules, 2014
- Canonical and Non-Canonical Barriers Facing AntimiR Cancer TherapeuticsCurrent Medicinal Chemistry, 2013
- Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cellsRadiation Oncology, 2012
- C/EBP expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathwayHaematologica, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transferJournal of Hematopathology, 2008
- MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancerOncogene, 2007
- MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma CellsCancer Research, 2005
- MicroRNAsCell, 2004